Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21/WAF1/CIP1 expression.
about
Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosisSomatic cell type specific gene transfer reveals a tumor-promoting function for p21(Waf1/Cip1)p21 in cancer: intricate networks and multiple activitiesPrognostic factors in prostate cancer.Tumor suppression by miR-31 in esophageal carcinoma is p21-dependent.Persistent, biologically meaningful prostate cancer after 1 year of androgen ablation and docetaxel treatment.Multi-transcript profiling in archival diagnostic prostate cancer needle biopsies to evaluate biomarkers in non-surgically treated men.Ligand-dependent corepressor (LCoR) recruitment by Kruppel-like factor 6 (KLF6) regulates expression of the cyclin-dependent kinase inhibitor CDKN1A gene.CCAAT/Enhancer binding protein β controls androgen-deprivation-induced senescence in prostate cancer cells.Inhibitor of p52 NF-κB subunit and androgen receptor (AR) interaction reduces growth of human prostate cancer cells by abrogating nuclear translocation of p52 and phosphorylated AR(ser81).A novel p21 attenuator which is structurally related to sorafenib.Early effects of pharmacological androgen deprivation in human prostate cancer.AR, the cell cycle, and prostate cancer.EGFR and SYNE2 are associated with p21 expression and SYNE2 variants predict post-operative clinical outcomes in HBV-related hepatocellular carcinoma.Galectin-3 regulates p21 stability in human prostate cancer cells.Overcoming adaptive resistance in mucoepidermoid carcinoma through inhibition of the IKK-β/IκBα/NFκB axisThe AR dependent cell cycle: mechanisms and cancer relevance.The role of treatment modality on the utility of predictive tissue biomarkers in clinical prostate cancer: a systematic review.A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer.TRIM3, a tumor suppressor linked to regulation of p21(Waf1/Cip1.).Inhibitory effects of antagonists of growth hormone releasing hormone on experimental prostate cancers are associated with upregulation of wild-type p53 and decrease in p21 and mutant p53 proteins.Chronic administration of valproic acid inhibits PC3 cell growth by suppressing tumor angiogenesis in vivo.Low-dose genistein induces cyclin-dependent kinase inhibitors and G(1) cell-cycle arrest in human prostate cancer cells.Cell proliferation and apoptosis in prostate tumors and adjacent non-malignant prostate tissue in patients at different time-points after castration treatment.Impact of differential cyclin D1 expression and localisation in prostate cancer.Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.Targeting histone deacetylase and NFκB signaling as a novel therapy for Mucoepidermoid Carcinomas.
P2860
Q24338676-1AEB7B7E-C28C-4D12-838B-900142396083Q28513336-93CCF937-A104-41C8-B18A-B478A43EB055Q30436015-06BEC628-07D1-4FDA-ADB4-3DD66F349567Q34682069-DC7B3FE5-E8D6-408F-B30D-03DD9458AE8CQ34786656-35A40629-2F6B-4E62-9391-0C98829E80C9Q35112059-BAC687B3-E8AB-42FA-9739-7D4551B1382EQ35256915-6C061DBA-7663-482D-AC29-DF4E9E92465EQ35841857-50EF766E-9096-45DA-8647-3CC6BFE3BCC3Q36069139-C6408AEF-0E6F-485A-A1F8-9D9BC1B3CB22Q36248478-7B181C3E-5641-4B61-A272-4E7CB0C7E7E1Q36677729-7999A903-9D5B-41E7-8E49-5804D6C32CB4Q36709642-FBEED4A9-C0D1-4CB4-9F56-BBD848D40CBFQ37095260-CD761F49-CC07-4FED-974B-A20A77CCD02BQ37159866-CFA1321B-6940-4E7B-8354-53970A666797Q37542482-242545F8-FA7F-4AB9-AF39-3D4A1BC54920Q37687338-1DC4454A-D4F3-464A-9D59-ED8698B458C0Q37904028-5B46DF12-677B-44BC-91CF-2D80CCA3F93EQ38063121-0131AEAE-AB49-40CC-9745-FD72E7CA4C26Q39144862-9A23A11C-F1B3-46FC-86F6-C0C6E9AD47FDQ39210791-E1B3EEC3-9F22-492D-A20D-7D24CD9DC729Q39499342-6A1BCBD7-14B2-45D0-830D-D0EFADDC51F6Q40087324-B0EF7F73-2A4A-44EA-AB26-F107923B60A7Q40842909-E656E7E0-2505-42B3-9ECC-BF634A7B229BQ42468173-47915C43-35C3-4C00-95CE-9887202FE82DQ43153660-4693BBDB-1E0B-42F9-A4BC-78B902E3A42AQ44059675-EAD815F9-F279-4C41-8C9B-59BD84F30DADQ48120446-2D2099E1-AF37-48C1-BED6-3D9EB58DA68F
P2860
Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21/WAF1/CIP1 expression.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Proliferation- and apoptosis-a ...... e of p21/WAF1/CIP1 expression.
@en
type
label
Proliferation- and apoptosis-a ...... e of p21/WAF1/CIP1 expression.
@en
prefLabel
Proliferation- and apoptosis-a ...... e of p21/WAF1/CIP1 expression.
@en
P2093
P2860
P356
P1476
Proliferation- and apoptosis-a ...... e of p21/WAF1/CIP1 expression.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6690390
P407
P577
1999-05-01T00:00:00Z
P5875
P6179
1028886926